Worst performer was JLP:Jubilee Metals which gave back all the gains that earned it Share of the Week last week. I'm still more optimistic about this one than I was 12 months ago.
KIBO:Kibo Energy is now my worst performing share and dropped a further 5% this week to go 90% down and with paper loss of £2,362. I'm beginning to doubt that any of its projects will happen, and forking out for power stations in UK that are never likely to fire up seems like folly.
CAML:Central Asia Metals is my best run company, and one of my favourite shares. It still managed to drop 5% this week and my holding is only 4% in the black. Last year it was making massive profits and about 35% up. However, if you factor in the £1,280 dividends I've had over the last 4 years, it's actually up by 18%. At these prices I had to buy more.
I love the story at VRS:Versarien, and it could be absolutely massive, but I've been increasingly concerned about them recently. The appointment of a guy to run the American operation who had to be sacked a few weeks later because he's on trial for multiple counts, a mass of MOUs but practically no orders for graphene, and a CEO who spends way too much time arguing with trolls on Twitter.
Their valuation is way higher than OPTI:Optibiotix, and OPTI has over 40 international contracts which are actually delivering revenue. It takes a long time to build a big business, and I think that realisation will hit shareholders soon. When it does there will be a re-rate like there was with OPTI. I made the mistake of buying just before the re-rate and sat on big losses for 3 years. I don't fancy that with VRS:Versdarien.
I sold my 1,505 shares for 101.166p and made a tiny £10.96 (0.7%) profit. This enabled my to buy another 705 shares in CAML:Central Asia Metals for 210.85p costing £1,498.44. My recent purchases have dragged up my initial price of 151p and 145p to a weighted average of 195.9p. My total holding is 4,607 shares costing £9,136.67 and a small paper profit of £387 (4%). They make up 9.4% of my portfolio cost and I want to get that to 10% as they are a great company.
Share f the Week is my only riser TLOU:Tlou Energy. This climbed 6% but is still 26% down. I still think this one is going to be a winner, but won't pile in any more as I've become risk averse to African mining and energy projects recently.
Last week was nice. This week less so.
Still above the trend line but no sign of it reversing.
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £27.14 | +£3.91 | |
| Portfolio cost | £57,921.93 | +£94.81 | |
| Portfolio sell value (bid price-commission) | £53,897.02 | (-6.9%) | -£1,206.43 |
| Potential profits | £7,319.25 | -£1,011.92 | |
| Yr 4 Dividends | £103.97 | +£15.90 | |
| Yr 4 Profit from sales | £1,692.71 | +£86.58 | |
| Yr 4 Average monthly cash profit | £158.48 | (3.3%) | +£5.73 |
| Total Dividends | £1,342.30 | +£15.90 | |
| Total Profit from sales | £20,389.83 | +£86.58 | |
| Average monthly cash profit | £457.64 | (9.5%) | -£0.15 |
| (Sold stocks profit + Dividends - Fees / Months) |
This is all rather complicated. First of all I had a £15 dividend from TND:Tandem Group, the share that just will not go into profit and let me sell them. The cost went up because I needed to buy back into SBTX:SkinBioTherapeutics when the price went below my target 20p. Unfortunately the cash I should have used to increase my holding from when I sold is stuck in IQE:IQE which has crashed. Instead I had to get the proceeds from my CWR:Ceres Power shares which were resting in C4XD:C4X Discovery Holdings.
I sold my 2,762 shares at 52p after buying at 48p making £86.58 (6.4%) profit. Unfortunately I only had enough to buy back 7,285 shares as opposed to the 9,260 I sold to put into IQE:IQE. Given the whole point of the exercise was to build my holding in SBTX:SkinBioTherapeutics the exercise has clearly failed miserably. If I manage to sell TND:Tandem Group I will put these into SBTX:SkinBioTherapeutics too, but only if the price stays below 20p.
The sale just meant my average monthly performance dropped by a bit less than usual, and general misery as the paper profits fell by £1,011 and losses deepened by and extra £200.
This account has spent far more time in the red than the black.
Very similar to the combined chart, except a bit worse.
The SIPP looks like this after week 188
| Weekly Change | |||
| Cash | £81.09 | -£3.71 | |
| Portfolio cost | £41,232.99 | -£15.69 | |
| Portfolio sell value (bid price - commission) | £41,212.19 | (-0.1%) | -£1,189.55 |
| Potential profits | £4,594.88 | -£1,084.24 | |
| Yr 4 Dividends | £361.99 | +£0 | |
| Yr 4 Interest | £0.08 | +£0.01 | |
| Yr 4 Profit from sales | £743.60 | +£10.95 | |
| Yr 4 Average monthly cash profit | £135.17 | (3.9%) | -£5.05 |
| Total Dividends | £1,704.24 | +£0 | |
| Total Interest | £0.11 | +£0.01 | |
| Total Profit from sales | £11,288.52 | +£10.95 | |
| Average monthly cash profit | £290.50 | (8.5%) | -£1.67 |
| (Sold stocks profit + Dividends - Fees / Months) |
Similar story to the ISA with £1,084 drop in potential profits and losses deepening by a further £100. The puny £10.95 profit from selling VRS:Versarien didn't change the average performance and I actually retained a bit of cash so the portfolio cost dropped a bit. Cash decreased despite retaining some profits because I paid £15 monthly charge.
I've decided to move my SIPP shares into fewer, safer companies so as I get rid of TRX:Tissue Regenix, SAE:Simec Atlantis Energy, N4P:N4 Pharma, MMX:Minds+Machines, and possibly IQE:IQE I will re-invest in CAML:Central Asia Metals, CEY:Centamin and a few blue chips I don't currently own. If I sold them all now I could re-invest £2,500 but I'm not prepared to lose the £4,600 as that would cripple my average performance. I just need to wait for them to recover or go bust.
The green line has just snuck beneath the red so we're back underwater.
Back below the trend line
The trading account looks like this
| Weekly Change | |||
| Cash | £35.04 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,434.97 | (-38.2%) | -£13.08 |
| Potential profits | £0 | +£0 | |
| Year 3 Dividends | £33.57 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £18.25 | (9.4%) | -£0.38 |
| Dividends | £34.72 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.83 | (-0.4%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Lots of small losses so we're down £13 and still no sign of being able to sell anything. TAP:Taptica have now changed their name to TRMR:Tremor but it hasn't helped the share price.
Just 4 more weeks and the week of the £2,000 injection will vanish off the chart. 12 whole months of nothing!
The trend line is so bad it's off the chart, so it would be difficult not to be above it.
That's it for another week. A couple of sales and I'm relieved to be out of VRS:Versarien but I'll watch them closely as I think they have a huge future, but there are too many amber flags for me to be there right now. So glad to be back in SBTX:SkinBioTherapeutics, but annoyed it's a smaller holding than I had before. I'm almost tempted to take the hit of the loss on TND:Tandem so I can get in below 20p and bolster my holding before inevitable news of a multinational partnership deal. Meanwhile the paid trolls have appeared in droves on the OPTI:Optibiotix bulletin board which means someone either wants cheap shares or has a big short. I suspect the former.
No comments:
Post a Comment